[go: up one dir, main page]

SG11201700485VA - Tungsten (vi) salts used to treat infertility, for stimulating fertility and normal reproduction in a non-diabetic female mammal, and for improving the effectiveness of assisted reproduction techniques - Google Patents

Tungsten (vi) salts used to treat infertility, for stimulating fertility and normal reproduction in a non-diabetic female mammal, and for improving the effectiveness of assisted reproduction techniques

Info

Publication number
SG11201700485VA
SG11201700485VA SG11201700485VA SG11201700485VA SG11201700485VA SG 11201700485V A SG11201700485V A SG 11201700485VA SG 11201700485V A SG11201700485V A SG 11201700485VA SG 11201700485V A SG11201700485V A SG 11201700485VA SG 11201700485V A SG11201700485V A SG 11201700485VA
Authority
SG
Singapore
Prior art keywords
tungsten
effectiveness
improving
salts used
female mammal
Prior art date
Application number
SG11201700485VA
Inventor
Almazán Ignacio Canals
Bugié Agnès Arbat
Original Assignee
Oxolife Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxolife Sl filed Critical Oxolife Sl
Publication of SG11201700485VA publication Critical patent/SG11201700485VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00Compounds of tungsten
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00Compounds of tungsten
    • C01G41/02Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Powder Metallurgy (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Inorganic Insulating Materials (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
SG11201700485VA 2014-07-21 2014-07-21 Tungsten (vi) salts used to treat infertility, for stimulating fertility and normal reproduction in a non-diabetic female mammal, and for improving the effectiveness of assisted reproduction techniques SG11201700485VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2014/070586 WO2016012632A1 (en) 2014-07-21 2014-07-21 Tungsten (vi) salts used to treat infertility, for stimulating fertility and normal reproduction in a non-diabetic female mammal, and for improving the effectiveness of assisted reproduction techniques

Publications (1)

Publication Number Publication Date
SG11201700485VA true SG11201700485VA (en) 2017-02-27

Family

ID=55162540

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201700485VA SG11201700485VA (en) 2014-07-21 2014-07-21 Tungsten (vi) salts used to treat infertility, for stimulating fertility and normal reproduction in a non-diabetic female mammal, and for improving the effectiveness of assisted reproduction techniques

Country Status (28)

Country Link
US (1) US10376540B2 (en)
EP (1) EP3173382B1 (en)
JP (1) JP6534439B2 (en)
KR (1) KR102282865B1 (en)
CN (1) CN106715332B (en)
AR (1) AR101252A1 (en)
AU (1) AU2014401750B2 (en)
BR (1) BR112017001287A2 (en)
CA (1) CA2955914C (en)
DK (1) DK3173382T3 (en)
ES (1) ES2940465T3 (en)
FI (1) FI3173382T3 (en)
HR (1) HRP20230223T1 (en)
HU (1) HUE061726T2 (en)
IL (1) IL250212B (en)
LT (1) LT3173382T (en)
MX (1) MX383705B (en)
PL (1) PL3173382T3 (en)
PT (1) PT3173382T (en)
RS (1) RS64025B1 (en)
RU (1) RU2679623C2 (en)
SG (1) SG11201700485VA (en)
SI (1) SI3173382T1 (en)
SM (1) SMT202300086T1 (en)
TW (1) TWI709407B (en)
UY (1) UY36222A (en)
WO (1) WO2016012632A1 (en)
ZA (1) ZA201701241B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019227122A1 (en) 2018-05-29 2019-12-05 The Flinders University Of South Australia Method for enhancing embryo implantation
EP4368577A1 (en) 2022-11-08 2024-05-15 Oxolife, S.L. Process for the preparation of tungsten (vi) salt hydrates

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2245374B1 (en) * 1973-07-27 1977-02-25 Anvar
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
ES2108642B1 (en) 1995-07-26 1998-08-16 Quimica Farm Bayer Sa TUNGSTEN (VI) COMPOSITIONS FOR THE ORAL TREATMENT OF DIABETES MELLITUS.
RU2202314C2 (en) * 2001-04-11 2003-04-20 Алексей Иванович Ступко Method for preparing female patients to artificial insemination
ES2187276B1 (en) * 2001-05-16 2004-08-01 Quimica Farmaceutica Bayer,S.A. ORAL COMPOSITIONS FOR THE TREATMENT OF OBESUS AND NON-DIABETIC HUMANS.
WO2004030687A1 (en) * 2002-10-02 2004-04-15 Yeda Research And Development Co. Ltd. Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
DE60331654D1 (en) * 2003-10-17 2010-04-22 Neurofood Ab Oy Non-radioactive strontium for the treatment of cancer
US7700280B2 (en) * 2003-12-31 2010-04-20 The Penn State Research Foundation Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer
CA2614210A1 (en) * 2005-07-05 2007-01-11 Adelaide Fertility Centre Pty Ltd Methods and compositions for improving pregnancy outcome
BRPI0613972A2 (en) * 2005-07-29 2011-02-22 Univ Barcelona pharmaceutical compositions for the treatment of neurodegenerative disorders
US20060100154A1 (en) * 2005-10-13 2006-05-11 Yeda Research And Development Co Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
PL2086642T3 (en) * 2006-10-18 2015-02-27 Periness Ltd Dnase for the treatment of male sub-fertility
ES2478790B1 (en) * 2013-01-22 2015-05-06 Oxolife, S. L. Use of tungsten salts (VI) for the treatment of female infertility in non-diabetic mammals
ES2551828B1 (en) * 2014-05-21 2016-09-12 Oxolife S.L. Food compositions comprising tungsten salts (VI)

Also Published As

Publication number Publication date
WO2016012632A9 (en) 2017-05-18
LT3173382T (en) 2023-03-27
CN106715332B (en) 2019-01-29
MX383705B (en) 2025-03-14
AR101252A1 (en) 2016-12-07
SMT202300086T1 (en) 2023-05-12
RS64025B1 (en) 2023-03-31
ES2940465T3 (en) 2023-05-08
TW201618796A (en) 2016-06-01
SI3173382T1 (en) 2023-04-28
RU2017105257A (en) 2018-08-21
JP2017523170A (en) 2017-08-17
HUE061726T2 (en) 2023-08-28
KR102282865B1 (en) 2021-07-28
PL3173382T3 (en) 2023-05-08
WO2016012632A1 (en) 2016-01-28
EP3173382A1 (en) 2017-05-31
FI3173382T3 (en) 2023-03-25
JP6534439B2 (en) 2019-06-26
IL250212A0 (en) 2017-03-30
RU2017105257A3 (en) 2018-08-21
DK3173382T3 (en) 2023-03-13
US20170173074A1 (en) 2017-06-22
HRP20230223T1 (en) 2023-04-14
ZA201701241B (en) 2022-05-25
US10376540B2 (en) 2019-08-13
BR112017001287A2 (en) 2018-01-30
TWI709407B (en) 2020-11-11
IL250212B (en) 2020-06-30
MX2017000927A (en) 2017-05-01
RU2679623C2 (en) 2019-02-12
KR20170029627A (en) 2017-03-15
EP3173382B1 (en) 2023-01-04
EP3173382A4 (en) 2018-03-21
NZ728467A (en) 2021-04-30
AU2014401750B2 (en) 2019-10-24
UY36222A (en) 2016-01-29
PT3173382T (en) 2023-03-10
CA2955914A1 (en) 2016-01-28
CN106715332A (en) 2017-05-24
CA2955914C (en) 2022-09-06
AU2014401750A1 (en) 2017-02-09

Similar Documents

Publication Publication Date Title
IL278124B (en) Pyridone derivative axl inhibitors for use in treating disease
IL243645B (en) Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders
ZA201508717B (en) Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor
EP3060685A4 (en) Methods of diagnosing and treating eosinophilic disorders
MX2018001289A (en) Combination therapies for treatment of cancer.
ZA201702247B (en) Use of reslizumab to treat moderate to severe eosinophilic asthma
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
EP3137082A4 (en) Methods to treat, prevent, and improve skin conditions
IL256329B (en) Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof
EP3240778A4 (en) Methods and agents for treating disease
EP3188800A4 (en) Compositions and methods for treating fibrosing disorders and cancer
IL240062A0 (en) Use of tungsten (vi) salts for the treatment of female infertility in non-diabetic mammals
ZA201701241B (en) Tungsten (vi) salts used to treat infertility, for stimulating fertility and normal reproduction in a non-diabetic female mammal, and for improving the effectiveness of assisted reproduction techniques
WO2015134603A3 (en) Methods for treating cancer
NZ726934A (en) Food compositions comprising tungsten (vi) salts
WO2015013285A3 (en) Methods for reducing the occurrence of hot flashes